openPR Logo
Press release

Embolotherapy Market to grow up to USD 7.7 billion by 2031, at a CAGR of 7.3% during the forecast period

08-01-2022 03:06 PM CET | Health & Medicine

Press release from: Global Insight Services

Embolotherapy Market to grow up to USD 7.7 billion by 2031, at

New York, Global Embolotherapy Market was valued at USD 3.8 billion in 2021 and it is anticipated to grow up to USD 7.7 billion by 2031, at a CAGR of 7.3% during the forecast period.

The global Embolotherapy market report from Global Insight Services is the single authoritative source of intelligence on Embolotherapy Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Read more about Embolotherapy Market here: https://www.globalinsightservices.com/reports/embolotherapy-market/

Embolotherapy is the process of obstructing arteries with a device (such as a balloon catheter) in order to treat or stop uncontrollable bleeding. Utilizing this technique, tumors are reduced, and bleeding is controlled. It is an endovascular procedure that attempts to stop bleeding by restricting aberrant blood arteries. Embolotherapy is mostly used to treat cervical uprooted pregnancy, postpartum situations, and pelvic tract hemorrhage.

Request sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10276/

Market Drivers and Trends

Because more target procedures are being performed on more target patients, the market for embolotherapy devices has been rising steadily over the past ten years. CVD is a major target illness, and research on successful and efficient treatments has focused on it because of its significance and high prevalence. Globally, more than 200 million people have peripheral vascular disorders as of 2017. The prevalence of these disorders increases with age, with the over-80 age group showing a prevalence rate of more than 20%.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10276/

Global Embolotherapy Market Segmental Overview

The report analyses the global embolotherapy market based on product, application, procedure, end user, and region.

Global Embolotherapy Market by Product

Based on product, it is segmented into embolization coil, embolic agents, detachable balloons, embolic plug systems, and support devices. The embolic agents segment is likely to dominate the market during the forecast period. The market growth of this segment is primarily driven by the surge in the prevalence of hepatocellular carcinoma combined with favorable reimbursement criteria in developed economies. Likewise, new product launches and approvals are further boosting the growth of the market.

Global Embolotherapy Market by Procedure

Based on procedure, it is segmented into transcatheter arterial embolization, transcatheter arterial chemoembolization, and transcatheter arterial radioembolization/selective internal radiation therapy. The transcatheter arterial embolization segment is likely to dominate the market during the forecast period. The key factors such as increasing demand for minimally invasive procedures coupled with growing prevalence of chronic diseases and rapid growth in the geriatric population are boosting the growth of the market.

Geographical Analysis of Global Embolotherapy Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific market is expected to hold the majority of the market share during the forecast period. Improving healthcare infrastructure in the region, the large patient population for target diseases, and expanding presence of key market players in the region to grab elevating opportunities offered by these countries are the key factors supporting the market growth in this region.

Major Players in the Global Embolotherapy Market

The key players studied in the global embolotherapy market are Boston Scientific Corporation (US), Merit Medical Systems (US), Terumo Corporation (Japan), Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), BTG plc (UK), Penumbra, Inc. (US), Cook Medical (US), Abbott Laboratories (US), Acandis GmbH (Germany), BALT Extrusion (France), Sirtex Medical Limited (Australia), Kaneka Corporation (Japan), and Meril Life Sciences Pvt. Ltd. (India).

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10276/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Embolotherapy Market to grow up to USD 7.7 billion by 2031, at a CAGR of 7.3% during the forecast period here

News-ID: 2695054 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Embolotherapy

Embolotherapy Market Size Expected to Hit $10.68 Billion by 2032
According to Value Market Research, the global Embolotherapy Market size is anticipated to experience significant growth, with expectations to reach nearly USD 10.68 billion by 2032, up from USD 4.87 billion in 2023. This growth corresponds to a robust compound annual growth rate (CAGR) of 9.12% during the forecast period from 2024 to 2032. The expansion of the market is attributed to advancements in embolotherapy technologies, increasing prevalence of chronic
Embolotherapy Market Future Prediction Report By 2031
Embolotherapy Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics. Request Sample
Embolotherapy Market Revenue to Reach US$ 5,758.28 Million by 2028
The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028. According to our new research study on "Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Disease Indication, Procedure, and End User," the market is expected to grow from US$ 3,341.49 million in
Embolotherapy Market 2023 Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Embolotherapy Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Embolotherapy Market Breakdown by Application (Hospitals and Clinics, Ambulatory Surgical Centers, Other End Users) by Type (Embolic Agents, Microspheres, Embolic Coils, Liquid Embolic Agents, Embolic Plug Systems, Detachable Balloons, Support Devices, Microcatheters, Guidewires) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Embolotherapy
Embolotherapy Market Growth, Development and Demand Forecast Report, 2030
The National Cancer Institute, under the U.S. Department of Health and Human Services, states that 76,080 new cases of kidney and renal pelvic cancer were diagnosed in the U.S. in 2021. Further, the Brain Aneurysm Foundation estimates that over 30,000 people suffer a brain aneurysm rupture every year in the U.S. Likewise, Brain Foundation of Migraine and Headache Australia states that approximately more than 2% of adults suffer from aneurysms
Embolotherapy Market 2022 - 2028 Worldwide Major Industry Players' Review
The "Global Embolotherapy Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Embolotherapy Market with detailed market segmentation by type, application, end user and geography. The global Embolotherapy Market is expected to witness high growth during the forecast period. The report provides key statistics on the